Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-06-14
2011-06-14
Chu, Yong (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C549S071000
Reexamination Certificate
active
07960431
ABSTRACT:
Disclosed herein is a compound according to one of the formulas or a pharmaceutically acceptable salt thereof, medicaments for the treatment of glaucoma or ocular hypertension and compositions related thereto, as further elaborated herein.
REFERENCES:
patent: 6586463 (2003-07-01), deLong et al.
patent: 2005/0209337 (2005-09-01), Gutman et al.
patent: WO 00/51977 (2000-02-01), None
patent: WO02096868 (2002-12-01), None
patent: WO 2006/022966 (2006-03-01), None
U.S. Appl. No. 60/805,285, filed Jun. 20, 2006, David W. Old, et al.
Francis A. Carey, Organic Chemistry, New York: McGraw-Hill Book Company 1987, p. 63.
Smith and March, March's Advanced Organic Chemistry, Fifth Ed., New York: Wiley-Interscience, 2001, pp. 1195-1196.
Burk Robert M.
Donde Yariv
Johnson Brent A.
Old David W.
Allergan Inc.
Chu Yong
Ene Doina G.
Forrestal Kevin J.
Rodriguez-Garcia Valerie
LandOfFree
Thiophenyl prostaglandin derivatives for treating glaucoma... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thiophenyl prostaglandin derivatives for treating glaucoma..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thiophenyl prostaglandin derivatives for treating glaucoma... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2637007